T cell line-mediated EAE: prevention and therapy by a monoclonal antibody specific for T lymphoblasts
- 1 April 1987
- journal article
- research article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 14 (3) , 339-343
- https://doi.org/10.1016/0165-5728(87)90020-8
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Therapy of rat autoimmune disease by a monoclonal antibody specific for T lymphoblasts.The Journal of Immunology, 1986
- Inhibition of rat autoimmune T cell activation by monoclonal antibodiesJournal of Neuroimmunology, 1986
- Prevention of type II collagen-induced arthritis by in vivo treatment with anti-L3T4.The Journal of Experimental Medicine, 1985
- Reversal of Experimental Allergic Encephalomyelitis with Monoclonal Antibody to a T-Cell Subset MarkerScience, 1985
- Experimental allergic encephalomyelitis: successful treatment in vivo with a monoclonal antibody that recognizes T helper cells.The Journal of Immunology, 1984
- Modulation of experimental allergic encephalomyelitis in lewis rats by monoclonal anti-T cell antibodiesJournal of Neuroimmunology, 1984
- Treatment of (NZB x NZW)F1 disease with anti-I-A monoclonal antibodies.The Journal of Experimental Medicine, 1983
- Autoimmune effector cells. V.A monoclonal antibody specific for rat helper T lymphocytes inhibits adoptive transfer of autoimmune encephalomyelitis.The Journal of Immunology, 1983
- In vivo effects of antibodies to immune response gene products: prevention of experimental allergic encephalitis.Proceedings of the National Academy of Sciences, 1981
- The rapid isolation of clonable antigen‐specific T lymphocyte lines capable of mediating autoimmune encephalomyelitisEuropean Journal of Immunology, 1981